• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    CARMAT Resumes Commercial Artificial Heart Implants

    Junkosha Plans New Facility in Kasama, Japan

    Philips-Medisize Introduces Disposable Pen Injector

    Japanese Universities Start Joint Trials for Fall Detection Tech

    FDA Clears H2o Therapeutics' Parkinson's Disease Monitoring App
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    LEMO USA Inc.

    Providence Enterprise USA Inc.

    Halkey-Roberts Corporation

    Paragon Medical

    JBC Technologies
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    LEMO USA Inc.

    Providence Enterprise USA Inc.

    Halkey-Roberts Corporation

    Paragon Medical

    JBC Technologies
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    LivaNova Clinical Study to Evaluate Treatment Outcomes for Microburst VNS Therapy System

    First patient enrolled at Rush University Medical Center in Illinois.

    Related Content
    • LivaNova, Verily Begin Difficult-to-Treat Depression Study
    • Medtech M&A Off to a Strong Start in 2018
    • Software Validation: How It Should Be Done
    • FDA's Expansion of 510(k) Program Seeks to End Predicate Testing for Some Devices
    • Monteris Medical NeuroBlate System Recalled Over Unexpected Laser Delivery Probe Heating
    Business Wire05.02.18
    LivaNova PLC has launched and enrolled the first patient in a clinical study to examine the use of its new Microburst Vagus Nerve Stimulation Therapy (VNS Therapy) System. This feasibility study will determine the initial safety and effectiveness of delivering VNS Therapy using high frequency bursts of stimulation (Microburst) in patients who have drug-resistant epilepsy (DRE).
     
    “LivaNova is launching this study to enrich our understanding of epilepsy patient populations and the significant role VNS Therapy can play in the overall management of this disease,” said Edward Andrle, LivaNova’s general manager of its Neuromodulation business franchise. “Through the Microburst feasibility study, we have the opportunity to evaluate a prospective new feature for VNS Therapy where stimulation is delivered in higher frequency bursts rather than gradual intervals.”
     
    The Microburst feasibility study’s first patient was enrolled by Dr. Rebecca O’Dwyer, assistant professor of Neurology, at the Rush University Medical Center in Chicago, Ill. The pre-market study consists of two cohorts, enrolling up to 40 patients in total at approximately 15 sites in the United States. Cohort 1 will include 20 patients with primary generalized tonic-clonic seizures. Cohort 2 will consist of 20 patients with partial onset seizures, including complex partial seizures with or without secondary generalization. Each patient will participate in the study for a minimum of 15 months. Primary endpoints will measure the percent change in seizure frequency and occurrence of stimulation-related adverse events in comparison to a patient’s baseline. Activation of various areas of the brain in response to stimulation will be assessed using functional magnetic resonance imaging or fMRI. Secondary endpoints will be evaluated to assess changes from baseline in seizure severity, quality of life, antiepileptic drug use, suicidality and adverse events.
     
    “At the Rush Epilepsy Center, we are very dedicated to research and advancing the field of epilepsy therapeutics for patients,” said O’Dwyer. “It is an honor to have enrolled the first patient in the Microburst VNS Therapy Feasibility Study, and we look forward to the resulting impact it will have on this patient population.”
     
    VNS Therapy received CE Mark in 1994 and U.S. Food and Drug Administration approval in 1997 as an adjunctive treatment for drug-resistant epilepsy. The system consists of two implantable components: a programmable electronic pulse generator that is connected to a bipolar electrical lead, which sends mild pulses to stimulate the vagus nerve at regular intervals throughout the day.
     
    LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. LivaNova’s technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems. Headquartered in London, United Kingdom, LivaNova has a presence in more than 100 countries worldwide. The company currently employs more than 4,500 employees, inclusive of approximately 900 employed by its CRM business franchise. LivaNova operates as three business franchises: Cardiac Surgery, Neuromodulation, and Cardiac Rhythm Management, with operating headquarters in Mirandola, Italy; Houston, Texas; and Clamart, France; respectively.
    Related Searches
    • market
    • medical
    • therapy
    • livanova
    Suggested For You
    LivaNova, Verily Begin Difficult-to-Treat Depression Study LivaNova, Verily Begin Difficult-to-Treat Depression Study
    Medtech M&A Off to a Strong Start in 2018 Medtech M&A Off to a Strong Start in 2018
    Software Validation: How It Should Be Done Software Validation: How It Should Be Done
    FDA FDA's Expansion of 510(k) Program Seeks to End Predicate Testing for Some Devices
    Monteris Medical NeuroBlate System Recalled Over Unexpected Laser Delivery Probe Heating Monteris Medical NeuroBlate System Recalled Over Unexpected Laser Delivery Probe Heating
    LivaNova to Divest Cardiac Rhythm Management Business to Microport Scientific LivaNova to Divest Cardiac Rhythm Management Business to Microport Scientific
    FDA Expands Heart Valve Approval to Include Size for Newborn Patients FDA Expands Heart Valve Approval to Include Size for Newborn Patients
     LivaNova Announces CE Mark for PureFlex Arterial Cannulae Line for Conventional Cardiac Surgery LivaNova Announces CE Mark for PureFlex Arterial Cannulae Line for Conventional Cardiac Surgery
    AngioDynamics Receives FDA Expedited Access Pathway Designation for the NanoKnife System AngioDynamics Receives FDA Expedited Access Pathway Designation for the NanoKnife System
    LivaNova to Acquire TandemLife for $250M LivaNova to Acquire TandemLife for $250M
    FDA Warns BD About Blood Collection Tubes Used in Lead Testing Kit FDA Warns BD About Blood Collection Tubes Used in Lead Testing Kit
    LivaNova Awards ECA with 2017 Supplier of the Year LivaNova Awards ECA with 2017 Supplier of the Year
    LivaNova to Acquire ImThera Medical LivaNova to Acquire ImThera Medical
    FDA Approves First Breakthrough-Designated Next-Gen Sequencing IVD Cancer Test FDA Approves First Breakthrough-Designated Next-Gen Sequencing IVD Cancer Test
    The Final Four: My Top Headlines for 2017 The Final Four: My Top Headlines for 2017

    Related Breaking News

    • Neurological
      LivaNova, Verily Begin Difficult-to-Treat Depression Study

      LivaNova, Verily Begin Difficult-to-Treat Depression Study

      Verily research tools will evaluate real-world VNS Therapy effectiveness as adjunctive difficult-to-treat depression treatment.
      Sam Brusco, Associate Editor 04.27.21

    • Medtech M&A Off to a Strong Start in 2018

      Medtech M&A Off to a Strong Start in 2018

      ...
      Mark Bonifacio, President, Bonifacio Consulting Services 05.03.18

    • Software & IT
      Software Validation: How It Should Be Done

      Software Validation: How It Should Be Done

      With vague guidance from FDA, device makers need to ensure they are using best practices.
      Erin Wright, Validation Product Manager, MasterControl 04.26.18


    • Testing
      FDA

      FDA's Expansion of 510(k) Program Seeks to End Predicate Testing for Some Devices

      Voluntary, modern 510(k) pathway may enable moderate risk devices to more efficiently demonstrate safety and effectiveness.
      U.S. Food and Drug Administration 04.13.18

    • Neurological | Surgical
      Monteris Medical NeuroBlate System Recalled Over Unexpected Laser Delivery Probe Heating

      Monteris Medical NeuroBlate System Recalled Over Unexpected Laser Delivery Probe Heating

      In some cases, the Laser Delivery Probes interacted with the MRI used to visualize catheter position, heating the probe.
      U.S. Food and Drug Administration 03.23.18

    Loading, Please Wait..

    Trending
    • The Future Of Biomedical Engineering Advancements
    • Medtronic's Recall Of Mahurkar Catheters Is Class I
    • Cirtec Medical Corporation Acquires Precision Components Business From QMD
    • Environmental Sustainability Becoming Increasingly Important To Medtech Industry
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    Breaking News
    • Sissel Lønning Andresen Named LINK Medical CEO
    • CARMAT Resumes Commercial Artificial Heart Implants
    • Junkosha Plans New Facility in Kasama, Japan
    • Philips-Medisize Introduces Disposable Pen Injector
    • Japanese Universities Start Joint Trials for Fall Detection Tech
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women
    BAPP Paper Reviews Common Adulteration Practices Which Go Undetected
    CRN Announces Promotions and Welcomes New Staff Member
    Coatings World

    Latest Breaking News From Coatings World

    ROSS Offers Heavy-Duty Three Roll Mills for High Viscosity Dispersions
    PPG Achieves ISO 14001 Certification of Environmental Management System
    AmCoat’s Rhino Shield and Floor Shield Break Records in 2022
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Junkosha Plans New Facility in Kasama, Japan
    Philips-Medisize Introduces Disposable Pen Injector
    Japanese Universities Start Joint Trials for Fall Detection Tech
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Dragonfly Therapeutics Appoints Joseph Eid as President of Research & Development
    CARBOGEN AMCIS Opens Sterile Liquid Drug Product Mfg. Facility in France
    ACG Appoints Vice President Sales for the Americas Region
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    e.l.f. Beauty Net Sales Grow 49% in Third Quarter of 2023
    DOVE Introduces ‘Next-Gen’ Body Wash in Sleek New Sustainable Bottle
    Ariana Grande Agrees to Purchase Assets Tied to r.e.m. beauty from Forma Brands
    Happi

    Latest Breaking News From Happi

    Ecolab Enters Consumer Retail with New Ecolab Scientific Clean Brand at Home Depot
    IPSY Partners with LA-Based Community Activist Dime Jones in Creation of February Glam Bag
    2023 Best New Product Awards in Beauty, Personal Care, Household Cleaning and More
    Ink World

    Latest Breaking News From Ink World

    Flint Group Launches Sustainable UV LED Dual Cure Ink
    Smurfit Kappa's Sustainable Solutions Take Home Eight WorldStar Awards
    Koenig & Bauer Adds Ran Landau as New SVP of Sales in North America
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    PPC Flexible Packaging acquires Isarel-based StePac, MAPfresh Holdings
    Flint Group launches sustainable UV LED dual cure ink
    KB Folie invests in first ThermoFlexX imager
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Qvin Menstrual Blood Diagnostic Device Receives FDA Approval in Thailand
    Andritz, KCF Technologies Form Agreement
    Freudenberg e-Power Systems, LG Energy Solution Announce Partnership
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Adrian Tyndall Joins Axogen's Board of Directors
    ADSM-Synchro Medical Acquired by Tyber Medical
    Solid Growth Ahead for Orthopedic Power Tools Market
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    LOPEC 2023: Here are the Highlights for Printed Electronics
    Employee-Led Giving at ORNL Provides $937,000 to Area Nonprofits in 2022
    Ambiq Captures Five 2023 AVA Digital Awards

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login